[{"NetIncomeLoss_1_Q1_USD":5685300.0,"UnrecognizedTaxBenefits_0_Q1_USD":0.0,"TemporaryEquityCarryingAmountAttributableToParent_0_Q1_USD":206650180.0,"AssetsCurrent_0_Q1_USD":736155.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_1_Q1_USD":0.0,"AccruedLiabilitiesCurrent_0_Q1_USD":80000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":135463.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"Liabilities_0_Q1_USD":19386072.0,"CommonStockSharesIssued_0_Q1_shares":23000000.0,"Cash_0_Q1_USD":573330.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":24707.0,"FairValueAdjustmentOfWarrants_1_Q1_USD":-5876670.0,"ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_0_Q1_shares":9483334.0,"FairValueAssetsLevel2ToLevel1TransfersAmount_0_Q1_USD":0.0,"AssetsHeldInTrustNoncurrent_0_Q1_USD":230300107.0,"SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares_0_Q1_shares":20665018.0,"UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_0_Q1_USD":0.0,"IncreaseDecreaseInAccruedLiabilities_1_Q1_USD":30000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":600000.0,"Assets_0_Q1_USD":231036262.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"FairValueAssetsLevel1ToLevel2TransfersAmount_0_Q1_USD":0.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"AdditionalPaidInCapital_0_Q1_USD":7656106.0,"RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty_1_Q1_USD":52500.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":573330.0,"AccountsPayableCurrent_0_Q1_USD":24707.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_1_Q1_USD":-343657.0,"LiabilitiesCurrent_0_Q1_USD":171572.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-343657.0,"CommonStockSharesOutstanding_0_Q1_shares":23000000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-2656904.0,"StockholdersEquity_0_Q1_USD":5000010.0,"ProfitLoss_1_Q1_USD":5685300.0,"CashFDICInsuredAmount_0_Q1_USD":250000.0,"SharePrice_0_Q1_USD":10.0,"PreferredStockSharesAuthorized_0_Q1_shares":1000000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":231036262.0,"PreferredStockValue_0_Q1_USD":null,"InvestmentIncomeInterest_1_Q1_USD":45958.0,"OperatingIncomeLoss_1_Q1_USD":-237328.0,"PrepaidExpenseCurrent_0_Q1_USD":162825.0,"IncreaseDecreaseInPrepaidExpense_1_Q1_USD":10351.0,"Ticker":"TOI","CIK":"1799191","name":"DFP HEALTHCARE ACQUISITIONS CORP.","OfficialName":"The Oncology Institute Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"520068227.0","Country":"United States","Sector":"Health Care","Industry":"Medical Specialities","Market":"NASDAQ","SP500":"nan","filed":"20210528"}]